Identifying the role of PTPN12 expression in predicting the efficacy of capecitabine to neoadjuvant chemotherapy in breast cancer treatment

Wang Y. -Y.; Liu H.; Mao X. -Y.; Jin F.; Ma B.; Jiang J. -Y.; Cao Y.

首页> 外文期刊>European review for medical and pharmacological sciences. >Identifying the role of PTPN12 expression in predicting the efficacy of capecitabine to neoadjuvant chemotherapy in breast cancer treatment

【24h】

Identifying the role of PTPN12 expression in predicting the efficacy of capecitabine to neoadjuvant chemotherapy in breast cancer treatment

机译：确定PTPN12表达在预测卡培他滨对乳腺癌新辅助化疗的疗效中的作用

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

OBJECTIVE: The aim of this study was to investigate the expression of PTPN12 in human breast cancer and its role in predicting the efficacy of neoadjuvant chemotherapy (NACT) for breast cancer.

机译：目的：研究PTPN12在人乳腺癌中的表达及其在预测新辅助化疗（NACT）对乳腺癌的疗效中的作用。

著录项

来源
《European review for medical and pharmacological sciences.》 |2016年第16期|共10页
作者
Wang Y. -Y.; Liu H.; Mao X. -Y.; Jin F.; Ma B.; Jiang J. -Y.; Cao Y.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药理学;
关键词
Breast cancer; PTPN12; Predictive factor; Capecitabine; Immunohistochemistry;

机译：乳腺癌;PTPN12;预测因子;卡培他滨;免疫组化;

相似文献

外文文献
中文文献
专利

1. Identifying the role of PTPN12 expression in predicting the efficacy of capecitabine to neoadjuvant chemotherapy in breast cancer treatment [J] . Wang Y. -Y., Liu H., Mao X. -Y., European review for medical and pharmacological sciences. . 2016,第16期

机译：确定PTPN12表达在预测卡培他滨对乳腺癌新辅助化疗的疗效中的作用
2. Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil-epirubicin-cyclophosphamide (FEC) in early-stage breast cancer: Exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy [J] . OhnoS., ChowL.W.C., SatoN., Breast cancer research and treatment. . 2013,第1期

机译：5-氟尿嘧啶-厄比霉素-环磷酰胺（FEC）4周期术后早期乳腺癌术前多西他赛联合或不联合卡培他滨的随机试验：探索性分析确定Ki67为新辅助化疗反应的预测生物标志物
3. Predictive role of midtreatment changes in survivin, gstp1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer [J] . EralpY., KeskinS., Ak?kE., American Journal of Clinical Oncology: Cancer Clinical Trials . 2013,第3期

机译：Survivin，gstp1和拓扑异构酶2α表达在中期治疗中的改变对局部晚期乳腺癌患者新辅助化疗的病理完全反应的预测作用
4. Radiomics for predicting response to neoadjuvant chemotherapy treatment in breast cancer [C] . Simona Rabinovici-Cohen, Tal Tlusty, Ami Abutbul, Conference on Imaging Informatics for Healthcare, Research, and Applications . 2020

机译：用于预测对乳腺癌新辅助化疗治疗的反应的辐射瘤
5. Using Preoperative Mri-guided Biopsies to Predict Pathologic Complete Response after Neoadjuvant Chemotherapy in Breast Cancer [D] . Kim, Jiyoon. 2019

机译：在乳腺癌新辅助化疗后使用术前Mri引导的活检来预测病理完全缓解
6. Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy [O] . S. Ohno, L. W. C. Chow, N. Sato, -1

机译：5-氟尿嘧啶-厄比霉素-环磷酰胺（FEC）4周期在早期乳腺癌中进行或不使用卡培他滨的术前多西他赛的随机试验：探索性分析确定Ki67为新辅助化疗反应的预测生物标志物
7. Randomized trial of preoperative docetaxel with or without capecitabine after 4 cycles of 5-fluorouracil–epirubicin–cyclophosphamide (FEC) in early-stage breast cancer: exploratory analyses identify Ki67 as a predictive biomarker for response to neoadjuvant chemotherapy [O] . 2013

机译：5-氟尿嘧啶-厄比霉素-环磷酰胺（FEC）4周期早期乳腺癌患者术前多西他赛联合或不联合卡培他滨的随机试验：探索性分析确定Ki67为新辅助化疗反应的预测生物标志物

Identifying the role of PTPN12 expression in predicting the efficacy of capecitabine to neoadjuvant chemotherapy in breast cancer treatment

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅